Especially on X, algorithmic culture is characterized by ceaseless iteration: Everything that’s happening is piled atop all ...
Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...
CloseMate today opened early access for the world's first Fully Autonomous CRM powered by AGI-grade logic, introducing a shift from Software as a Service to Service as Software, a paradigm where you ...
A new movement of people seeking connection and purpose forget they’re talking to AI and project their vulnerabilities onto ...
Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...
Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.